CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+4.05%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$6.32B
AUM Growth
+$456M
(+7.8%)
Cap. Flow
+$215M
Cap. Flow
% of AUM
3.4%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
847
New
72
Increased
349
Reduced
257
Closed
60
Top Buys
| 1 |
Broadcom
AVGO
|
$37.2M |
| 2 |
Bristol-Myers Squibb
BMY
|
$30.1M |
| 3 |
Biogen
BIIB
|
$28.3M |
| 4 |
Home Depot
HD
|
$23.7M |
| 5 |
Cisco
CSCO
|
$20.7M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
$22.4M |
| 2 |
TJX Companies
TJX
|
$20.9M |
| 3 |
Intuit
INTU
|
$15.7M |
| 4 |
FedEx
FDX
|
$15M |
| 5 |
lululemon athletica
LULU
|
$13.4M |
Sector Composition
| 1 | Healthcare | 25.18% |
| 2 | Technology | 17.2% |
| 3 | Financials | 12.85% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Communication Services | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TFCFA
276
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $5.44M | 0.09% |
109,395
-16,687
| -13% | -$829K |
|
|
WBA
277
DELISTED
Walgreens Boots Alliance
WBA
| $5.42M | 0.09% |
90,217
+1,703
| +2% | +$102K |
|
|
RTN
278
DELISTED
Raytheon Company
RTN
| $5.31M | 0.08% |
27,472
-2,088
| -7% | -$403K |
|
279
Canadian National Railway
CNI
$60.3B
| $5.29M | 0.08% |
64,751
+3,636
| +6% | +$297K |
|
280
Apellis Pharmaceuticals
APLS
$3.55B
| $5.28M | 0.08% |
240,000
+116,000
| +94% | +$2.55M |
|
|
WRK
281
DELISTED
WestRock Company
WRK
| $5.27M | 0.08% |
92,498
+69,083
| +295% | +$3.94M |
|
282
PTC Therapeutics
PTCT
$4.55B
| $5.26M | 0.08% |
156,000
+34,000
| +28% | +$1.15M |
|
283
Agnico Eagle Mines
AEM
$76.3B
| $5.25M | 0.08% |
114,581
-114,705
| -50% | -$5.26M |
|
284
Air Products & Chemicals
APD
$64.5B
| $5.24M | 0.08% |
33,669
+8,425
| +33% | +$1.31M |
|
285
Kimberly-Clark
KMB
$43.1B
| $5.21M | 0.08% |
49,448
+15,497
| +46% | +$1.63M |
|
286
Prologis
PLD
$105B
| $5.19M | 0.08% |
78,945
+16,522
| +26% | +$1.09M |
|
|
287
FedEx
FDX
$53.7B
| $5.16M | 0.08% |
22,718
-66,035
| -74% | -$15M |
|
288
Lincoln National
LNC
$7.98B
| $5.16M | 0.08% |
82,801
-138,492
| -63% | -$8.62M |
|
|
RETA
289
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.13M | 0.08% |
146,700
+54,700
| +59% | +$1.91M |
|
290
CME Group
CME
$94.4B
| $5.13M | 0.08% |
31,280
+3,262
| +12% | +$535K |
|
291
Goodyear
GT
$2.43B
| $5.12M | 0.08% |
219,798
+187,500
| +581% | +$4.37M |
|
|
TIF
292
DELISTED
Tiffany & Co.
TIF
| $5.03M | 0.08% |
38,253
-36,849
| -49% | -$4.85M |
|
293
BCE
BCE
$23.1B
| $5.03M | 0.08% |
124,163
+30,368
| +32% | +$1.23M |
|
294
Corpay
CPAY
$22.4B
| $4.92M | 0.08% |
+23,335
| New | +$4.92M |
|
295
Labcorp
LH
$23.2B
| $4.91M | 0.08% |
31,826
-18
| -0.1% | -$2.78K |
|
296
Aflac
AFL
$57.2B
| $4.88M | 0.08% |
113,366
+6,896
| +6% | +$297K |
|
297
Scotiabank
BNS
$78.8B
| $4.73M | 0.07% |
83,552
+3,621
| +5% | +$205K |
|
298
Oneok
OKE
$45.7B
| $4.72M | 0.07% |
67,582
+3,795
| +6% | +$265K |
|
|
XLRN
299
DELISTED
Acceleron Pharma Inc.
XLRN
| $4.71M | 0.07% |
97,000
+37,000
| +62% | +$1.8M |
|
|
RVNC
300
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.69M | 0.07% |
171,000
| – | – |
|